• AdvaMed Statement on 21st Century Cures Discussion Draft

    By: Press Release | January 27, 2015

    “AdvaMed commends Chairman Upton and Congresswoman DeGette for their leadership on the 21st Century Cures initiative. We share their goal of accelerating the discovery, development and delivery of cures for patients, and we applaud their leadership on this important issue.

  • SOTU Reaction: AdvaMed Applauds Free Trade, Calls for Device Tax Repeal to Advance Innovation Economy

    By: Press Release | January 21, 2015

    “AdvaMed applauds the president’s ongoing support for international trade. U.S. medical technology manufacturers need a level playing field to retain their global leadership. We look forward to supporting a strong and ambitious Trans-Pacific Partnership (TPP) that includes solid provisions on transparency and procedural fairness, and addresses important technical regulatory barriers."

  • AdvaMed, MITA & MDMA Applaud Bipartisan Senate Effort to Repeal the Device Tax

    By: Press Release | January 13, 2015

    “This tax is an anchor on American economic growth. Our industry has long been an engine of growth, driving medical innovation and producing well-paying manufacturing and advanced science and technical jobs. That’s why there is broad bipartisan support to repeal this tax and we urge Congress to act quickly,” said Stephen J. Ubl, President and CEO of AdvaMed. “Today’s news that U.S. leadership in medical research is eroding underscores the need to address this tax quickly before further harm is done.”

Payment Review & Alerts

The Payment & Policy Review is a new monthly communication from AdvaMed’s Payment and Health Care Delivery Policy Department that provides a short summary of important activities, reports, letters, meetings, etc. that relate to Medicare payment, coverage and quality issues.

READ MORE